For example, decreased METTL3 expression or METTL14 mutation in endometrial cancer reduces the m6A modification of AKT pathway-related genes, resulting in the activation of the AKT signaling pathway and contributing to tumorigenesis [10]. Here, METTL3 is linked to endometrial cancer.